162 related articles for article (PubMed ID: 34923809)
1. Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide.
Oortwijn W; Jansen M; Baltussen R
Int J Health Policy Manag; 2022 Oct; 11(10):2327-2336. PubMed ID: 34923809
[TBL] [Abstract][Full Text] [Related]
2. Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design - Part I: Conceptual Framework.
Baltussen R; Jansen M; Oortwijn W
Int J Health Policy Manag; 2022 Oct; 11(10):2319-2326. PubMed ID: 34923808
[TBL] [Abstract][Full Text] [Related]
3. Moral and Social Values in Evidence-Informed Deliberative Processes for Health Benefit Package Design Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
DiStefano MJ
Int J Health Policy Manag; 2023; 12():7480. PubMed ID: 37579447
[TBL] [Abstract][Full Text] [Related]
4. Challenges and Opportunities for Deliberative Processes for Healthcare Decision-Making Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
Bond K
Int J Health Policy Manag; 2023; 12():7458. PubMed ID: 35988028
[TBL] [Abstract][Full Text] [Related]
5. Three Approaches to Improve a Practical Guide on Evidence-Informed Deliberative Processes for Health Benefit Package Design Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
Guzman J
Int J Health Policy Manag; 2023; 12():7502. PubMed ID: 36086853
[TBL] [Abstract][Full Text] [Related]
6. Evidence-Informed Deliberative Processes for UHC: Progress, Potential and Prudence Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
Gopinathan U
Int J Health Policy Manag; 2023; 12():7541. PubMed ID: 37579471
[TBL] [Abstract][Full Text] [Related]
7. Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.
Oortwijn W; Jansen M; Baltussen R
Int J Health Policy Manag; 2020 Jan; 9(1):27-33. PubMed ID: 31902192
[TBL] [Abstract][Full Text] [Related]
8. Implementing evidence-informed deliberative processes in health technology assessment: a low income country perspective.
Kapiriri L; Baltussen R; Oortwijn W
Int J Technol Assess Health Care; 2020; 36(1):29-33. PubMed ID: 31944173
[TBL] [Abstract][Full Text] [Related]
9. Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
Gopinathan U; Ottersen T; Cyr PR; Chalkidou K
Int J Health Policy Manag; 2021 Mar; 10(4):232-236. PubMed ID: 32772012
[TBL] [Abstract][Full Text] [Related]
10. Deliberative processes in health technology assessment of medicines: the case of Spain.
Pinilla-Dominguez P; Pinilla-Dominguez J
Int J Technol Assess Health Care; 2023 Jul; 39(1):e50. PubMed ID: 37403252
[TBL] [Abstract][Full Text] [Related]
11. Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes.
Baltussen R; Jansen MPM; Bijlmakers L; Grutters J; Kluytmans A; Reuzel RP; Tummers M; der Wilt GJV
Value Health; 2017 Feb; 20(2):256-260. PubMed ID: 28237205
[TBL] [Abstract][Full Text] [Related]
12. The Use of Evidence-Informed Deliberative Processes for Health Benefit Package Design in Kazakhstan.
Oortwijn W; Surgey G; Novakovic T; Baltussen R; Kosherbayeva L
Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141691
[TBL] [Abstract][Full Text] [Related]
13. Towards Integrated Health Technology Assessment for Improving Decision Making in Selected Countries.
Oortwijn W; Determann D; Schiffers K; Tan SS; van der Tuin J
Value Health; 2017 Sep; 20(8):1121-1130. PubMed ID: 28964444
[TBL] [Abstract][Full Text] [Related]
14. Addressing Health System Values in Health Technology Assessment: The Use of Evidence-Informed Deliberative Processes.
Oortwijn W; Klein P
Int J Technol Assess Health Care; 2019; 35(2):82-84. PubMed ID: 30957730
[TBL] [Abstract][Full Text] [Related]
15. Application of evidence-informed deliberative processes in health technology assessment in low- and middle-income countries.
Oortwijn W; van Oosterhout S; Kapiriri L
Int J Technol Assess Health Care; 2020 Jul; ():1-5. PubMed ID: 32715993
[TBL] [Abstract][Full Text] [Related]
16. Harnessing Country Experiences for Health Benefit Package Design: Evidence-Informed Deliberative Processes and Experiences From the Joint Learning Network Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
Nagpal S; Ahluwalia N; Hashiguchi LO; McGee K; Lutalo M
Int J Health Policy Manag; 2023; 12():7856. PubMed ID: 38618786
[TBL] [Abstract][Full Text] [Related]
17. Use of Evidence-Informed Deliberative Processes - Learning by Doing Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
Culyer AJ
Int J Health Policy Manag; 2020 Jun; 9(6):263-265. PubMed ID: 32613796
[TBL] [Abstract][Full Text] [Related]
18. Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
Goetghebeur M; Cellier M
Int J Health Policy Manag; 2021 Mar; 10(4):228-231. PubMed ID: 32610794
[TBL] [Abstract][Full Text] [Related]
19. Reinforcing Science and Policy, With Suggestions for Future Research Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
Culyer AJ
Int J Health Policy Manag; 2023; 12():7398. PubMed ID: 35942975
[TBL] [Abstract][Full Text] [Related]
20. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.
Oortwijn W; Husereau D; Abelson J; Barasa E; Bayani DD; Santos VC; Culyer A; Facey K; Grainger D; Kieslich K; Ollendorf D; Pichon-Riviere A; Sandman L; Strammiello V; Teerawattananon Y
Int J Technol Assess Health Care; 2022 Jun; 38(1):e37. PubMed ID: 35656641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
